Characteristics of Intravenous Fluid Infiltration and Factors Associated With Adverse Events: A Multicenter Retrospective Study

被引:0
作者
Duggan, Jessica L. [1 ]
Lechtig, Aron [1 ]
Watkins, Ian T. [1 ]
Lans, Jonathan [1 ]
von Keudell, Arvind [2 ]
Zhang, Dafang [2 ]
机构
[1] Harvard Combined Orthopaed Residency Program, 55 Fruit St, Boston, MA 02114 USA
[2] Brigham & Womens Hosp, Boston, MA USA
来源
HAND-AMERICAN ASSOCIATION FOR HAND SURGERY | 2024年
关键词
consultation; compartment syndrome; complications; extravasation; infiltration; COMPARTMENT SYNDROME; EXTRAVASATION; HAND; MANAGEMENT;
D O I
10.1177/15589447241302359
中图分类号
R826.8 [整形外科学]; R782.2 [口腔颌面部整形外科学]; R726.2 [小儿整形外科学]; R62 [整形外科学(修复外科学)];
学科分类号
摘要
Background: Peripheral intravenous (PIV) infiltration and extravasation are common complications of intravenous fluid administration. Here, we aim to investigate risk factors associated with major adverse events following PIV infiltration, which may help risk stratify those who require early surgical consultation.Methods: Retrospectively, patients were identified who had a documented PIV infiltration or extravasation event at 3 academic hospitals between 2015 and 2022. A major adverse advent was defined as a full-thickness injury requiring operative management (deep infection, compartment syndrome). A minor adverse event was defined as superficial injury (cellulitis, superficial thrombosis).Results: In total, 160 patients with PIV infiltration events were included (37.5% men), with an average age of 64.1 years. A surgical consult for a hand specialist was placed 35% of the time: orthopedic surgery in 46.4% of cases and plastic surgery in 42.9%. Among these consults, 87.5% recommended supportive treatment (elevation, warm/cold compresses, serial examinations). Major adverse events occurred in 4.4% (n = 7) of patients, and minor adverse events occurred in 11.3% (n = 18). Both intensive care unit (ICU) admission and current intubation status (ie, intubated, sedated, and nonexaminable) at the time of infiltration were significantly associated with adverse events (P = .02 and P = .03, respectively). Current intubation status was significantly associated with operative management (P = .001).Conclusion: Robust characterization of PIV infiltration events may facilitate early identification of patients at risk of serious complications. We found ICU admission and current intubation both to be associated with adverse events following PIV infiltration. Further work should be done to evaluate the risk of infiltration with different fluid types (vesicant, nonvesicant).
引用
收藏
页数:7
相关论文
共 21 条
[1]  
Al-Benna S, 2013, ISRN Dermatol, V2013, P856541, DOI 10.1155/2013/856541
[2]  
Avdal E.U., 2012, International Journal of Caring Sciences, V5, P191
[3]  
Bahl A., 2023, Int J Nurs Health Care Res, V6, P1436
[4]   Percutaneous forefoot surgery [J].
Bauer, T. .
ORTHOPAEDICS & TRAUMATOLOGY-SURGERY & RESEARCH, 2014, 100 (01) :S191-S204
[5]   Risk factors for peripheral venous catheter failure: A prospective cohort study of 5345 patients [J].
Chen, Ya-mei ;
Fan, Xiao-wen ;
Liu, Ming-hong ;
Wang, Jie ;
Yang, Yi-qun ;
Su, Yu-fang .
JOURNAL OF VASCULAR ACCESS, 2022, 23 (06) :911-921
[6]   Outcomes and Management of Peripheral Intravenous Infiltration Injuries [J].
Gibian, Joseph T. ;
Zakria, Danny ;
March, Cooper ;
Schaheen, Basil ;
Drolet, Brian C. .
HAND-AMERICAN ASSOCIATION FOR HAND SURGERY, 2022, 17 (01) :148-154
[7]   Intravenous catheter complications in the hand and forearm [J].
Kagel, EM ;
Rayan, GM .
JOURNAL OF TRAUMA-INJURY INFECTION AND CRITICAL CARE, 2004, 56 (01) :123-127
[8]   Extravasation of Noncytotoxic Drugs: A Review of the Literature [J].
Le, Ann ;
Patel, Samit .
ANNALS OF PHARMACOTHERAPY, 2014, 48 (07) :870-886
[9]   Incidence, risk factors and medical cost of peripheral intravenous catheter-related complications in hospitalised adult patients [J].
Liu, Congcong ;
Chen, Lin ;
Kong, Dong ;
Lyu, Fangfang ;
Luan, Linlin ;
Yang, Lijuan .
JOURNAL OF VASCULAR ACCESS, 2022, 23 (01) :57-66
[10]   Management of Extravasation Injuries: A Focused Evaluation of Noncytotoxic Medications [J].
Reynolds, Paul M. ;
MacLaren, Robert ;
Mueller, Scott W. ;
Fish, Douglas N. ;
Kiser, Tyree H. .
PHARMACOTHERAPY, 2014, 34 (06) :617-632